OmniAb Names Amechi Nwachuku Chief Operating Officer

(NASDAQ:OABI), a provider of cutting-edge discovery research technology to enable the discovery of next-generation ...
The Manila Times

Antengene Announces Receipt of USD 60 Million Upfront Payment from UCB

SHANGHAI and HONG KONG, July 13, 2026 /PRNewswire/ -- Antengene Corporation Limited ('Antengene', SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering ...

TG Therapeutics (TGTX) Gains as Its Key Drug Exceeded Expectations

ClearBridge Investments, a global equity manager, recently published second-quarter 2026 commentary for its “SMID Cap Growth ...
American Association of Individual Investors

Which Is a Better Investment, Ionis Pharmaceuticals, Inc. or Nurix Therapeutics, Inc. Stock?

Learn more about whether Ionis Pharmaceuticals, Inc. or Nurix Therapeutics, Inc. is a better investment based on AAII's A+ ...

Charles River Provides NGS Services to Arovella Therapeutics, Accelerating Progress Toward Alternative Cancer Treatment Approaches

Charles River Laboratories International, Inc. (NYSE: CRL) today announced a collaboration with Arovella Therapeutics Ltd (ASX: ALA), a biotechnology company, to provide Good Manufacturing Practice ...
Frontiers

The gut–immune–brain axis in neurological disorders: microbial immunology and host–microbe interactions

The human gut harbors a vast and dynamic microbial ecosystem that extends far beyond its traditional role in digestion. Over the past decade, mounting ...